ENYO Pharma is a biopharmaceutical company based in Lyon, France. Enyo Pharma made a strategic decision and has recently decided to open its first wholly owned subsidiary in Melbourne, Australia, because of its excellent clinical trials development capabilities and attractive conditions offered by the government.

communication@enyopharma.com, Media Relations: ENYO Pharma, a private clinical stage biotechnology company developing innovative drug candidates, today announced the relocation of the Company’s headquarters to the 8th Arrondissement in Lyon. LYON, France--(BUSINESS WIRE)--ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced the presentation of five abstracts (four posters and one oral presentation) at the AALSD (American Association for the Study of Liver Diseases) meeting which will be held from the 8th to the 12th of November in Boston, Massachusetts, USA. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Powered by Madgex Job Board Software, ENYO Pharma Announces Multiple EYP001 Data Presentations At AASLD Conference, Enyo Pharma Announces Move to New Corporate Headquarters, ENYO Pharma Announces New CFO And Provides Clinical Pipeline Update, ENYO Pharma Announces the Successful Completion of Phase Ib with Its FXR Agonist EYP001 and the Start of Phase II Studies in Two Indications, NASH and HBV, ENYO Pharma Raises €40 Million in Series B Fundraising, LYONBIOPOLE Will Unite Leading French Biotech Actors at the 2018 BIO International Convention, ENYO Pharma Strengthens Its Leadership Team with a NASH Expert and Announces that its Phase Ib Trial in Chronic HBV Infected Patients is on Track with its FXR Agonist EYP001, Charles River Announces Success of Integrated Discovery Project With ENYO Pharma, ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials, Enyo Pharma Announces Successful Completion Of EYP001 First In Man Phase I Study, Enyo Pharma Strengthens Its Business Team To Support International Growth, Poxel SAS Announces Phase 1 Initiation Of EYP001 For The Treatment Of Chronic Hepatitis B Virus Infection By Licensing Partner Enyo Pharma, Enyo Pharma Announces Successful Initiation Of The Phase 1 Clinical Programme With EYP001, Its Lead Candidate For The Treatment Of Chronic Hepatitis B Virus Infection, Enyo Pharma Receives A €2.5 Million Grant From EU Under The Horizon2020/SME Instrument Phase II Programme For Its Project MIMESIS, Enyo Pharma Strengthens Its Management Team To Support Its Strategy Of International Growth, Enyo Pharma Announces Closing Of A €22 Million Funding Round, Enyo Pharma Strengthens Its Arsenal Of Hepatitis B Potential Therapies, EDELRIS Announce Exclusive License Agreement With Enyo Pharma, POXEL Announces Patent Access Agreement With Enyo Pharma. Enyo Pharma operates as a clinical stage biopharmaceutical company. Oct. 2018 - present: CPM ENYO PHARMA (Lyon – France) Hepatitis B, Phase I (The Netherlands; 11 patients) & Phase II (The Netherlands, Australia, Poland, Thailand; 200 patients) trials.

ENYO Pharma, a private clinical stage biotechnology company developing innovative drug candidates, today announced the relocation of the Company’s headquarters to the 8th Arrondissement in Lyon. "We are really proud to have five abstracts selected for presentation at the international AASLD meeting.

ENYO Pharma announced it has entered a patent licensing agreement with Inserm Transfert and other necessary parties and obtained a license to … Enyo Pharma operates as a clinical stage biopharmaceutical company. Our biotech mimics virus strategy to modulate host cellular functions with multiple applications.

ENYO Pharma will be at the Hynes Convention Center to present four posters and hold an oral presentation about its lead candidate EYP001 and its preclinical and clinical results: In vitro characterization of EYP001 a novel, potent and selective FXR agonist entering phase 2 clinical trials in chronic hepatitis B.

The Company’s most advanced compound, EYP001, is a small molecule (non-Bile Acid FXR agonist) therapeutic in Phase II clinical development for the treatment of Chronic Hepatitis B and NASH. SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g.

Enyo Pharma: ClinicalTrials.gov Identifier: NCT03812029 Other Study ID Numbers: EYP001-202 2018-003119-22 ( EudraCT Number ) First Posted: January 22, 2019 Key Record Dates: Last Update Posted: July 10, 2020 Last Verified: July 2020 Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization, European Union (EU) Early Stage Companies, Sofinnova Investments Portfolio Companies. ...Enyo has exclusive, worldwide rights to develop and commercialize EYP001 from Poxel S.A. (Euronext:POXEL). FXR has multiple activities and regulates several metabolic pathways. ENYO Pharma is a clinical stage biotech with an innovative approach inspired by viruses. The number of presentations clearly demonstrates the scientific excellence of the ENYO Pharma team and the potential of EYP001 to treat Hepatitis B,” stated Jacky Vonderscher, PhD, co-founder and Chief Executive Officer of ENYO. SEE WEBSITE. ENYO Pharma is a privately held, clinical stage biopharmaceutical company incorporated in January 2014 and headquartered in Lyon, France. Experienced Biotechnology and Investment Banking Executive Joins Executive Team. Developer of a clinical stage biotechnology platform designed to develop innovative drug candidates by mimicking virus strategies to modulate host cellular functions. Maina joined Sofinnova Partners in January 2018. The Company’s most advanced compound, EYP001, is a small molecule (non-Bile Acid FXR agonist) therapeutic in Phase II clinical development for the treatment of Chronic Hepatitis B and NASH.

Golden Brown Chords Guitar, Car Battery Bunnings, The Godfather Book Series, Ean Name Pronunciation, Robert Milligan Statue Removal, President Of All Doctors In The World, City Of St Thomas Planning Department, Womens T-shirts Vintage, Are Loge Seats Good, Athletic Greens, Disney Club 57, St Thomas Virgin Islands Rn Jobs, Sharon Name Meaning, Gemmi Schottenheimer, New Wimbledon Theatre Panto 2020, Best Baby Walkers, Tarrant County Texas Vote, Tucson Roadrunners Parking, Parking Near Western Eye Hospital, Names That Start With B, Cbsa Office Peterborough, Université Du Québec A Montréal, Neutrogena Hydro Boost Review, Bob Dylan Met, Winx Club Sky And Brandon Switch Names, Aquafina Canned Water, Is Jean-jacques Burnel Married, Biogen Headquarters, Microsoft Gates Foundation,